Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

EWEdwards Lifesciences Corporation

Healthcare·Medical Devices·NYSE·Mkt cap $40.00B
$91.81
-$0.36 (-0.40%) today
IEX feed · not consolidated
Last updated Jul 14, 10:13 AM
65/100 Opportunity
25Risk
65Momentum
66Pullback
65Quality
68Valuation
94Trend
Price & History (up to 5 years)
2025-09-11 → 2026-09-11
Low 72.65— support · — resistanceHigh 95.17
Technical Indicators
RSI (14)56.9
MACD hist-0.06
ATR (14)2.18
SMA 2090.20
SMA 5086.57
SMA 20083.01
Rel volume0.8x
Boll upper96.23
Boll lower84.18
52w high96.26
52w low72.30
5y high131.70
5y low58.94
Hist. vol25%
Max drawdown-13%
Sideways RangeBuy WatchPossible Dip BuyEntry: Pullback Watch
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Edwards Lifesciences Corporation — Medical Devices company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
65/100
Risk Level
Low-Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: EW is trading near recent levels (-0.4% today). Overall, the company is reasonably solid. It is in a longer-term sideways range. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context68
Valuation68
Trend94
Momentum65
Pullback66
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward46
Entry Timing55
Sell Risk30
Risk25

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.